Non-depolarizing NMJ blocker and antagonist at nAChRs and M2 mAChRs used to induce anesthesia. It relaxes skeletal muscles, prevents action potential shortening, and suppresses atrial fibrillation. (C003B-255958)

Catalog No.: C003B-255958
Mfr. No.: C3472-100 mg
Mfr. Name: LKT Laboratories, Inc
Qty/UOM: 1
UOM: EA

Price: $970.94

List Price: $1,078.83

Cisatracurium is a non-depolarizing neuromuscular junction (NMJ) blocker it binds the a-d interface of postsynaptic nicotinic acetylcholine receptors (nAChRs). Cisatracurium acts as a skeletal muscle relaxant and is an isomer of parent compound

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Cisatracurium is a non-depolarizing neuromuscular junction (NMJ) blocker; it binds the a-d interface of postsynaptic nicotinic acetylcholine receptors (nAChRs). Cisatracurium acts as a skeletal muscle relaxant and is an isomer of parent compound atracurium. Cisatracurium also suppresses atrial fibrillation and prevents action potential shortening in vivo, indicating additional inhibition of M2 muscarinic acetylcholine receptors (mAChRs) in the atrium. Grade: ≥95%

UPC:: 51152400
Condition:: New
Availability:: 3 Days
Weight:: 1.00 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: C3472-100 mg
CAS:: 96946-42-8

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."